Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds OPNT.
No tracked institution reports a position in OPNT as of their last filing.
| Execution date | Ratio |
|---|---|
| 2009-08-20 | 20-for-1 |
No one on the platform has traded OPNT yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-03-21 | $-2.46 | $0.11 | +104.5% |
| 2022-11-14 | $-1.49 | $-1.92 | -28.9% |
| 2022-08-11 | $-1.36 | $-2.31 | -69.9% |
| 2022-05-10 | $-0.91 | $-2.43 | -167.0% |
| 2022-03-15 | $0.01 | $0.11 | +1200.2% |
| 2021-11-11 | $0.21 | $0.56 | +166.7% |
| 2021-08-05 | $-0.28 | $0.31 | +210.7% |
| 2021-05-11 | $-0.71 | $-0.66 | +7.0% |
| $121M |
| — |
| HLVXHilleVax, Inc. | $2.09 | -0.48% | $105M | — |
| JNCEJounce Therapeutics, Inc. | $1.88 | +0.00% | $99M | — |
Source: Financial Modeling Prep · peers by sector/industry
$OPNT The deal was $20 pee share plus up to $8 in milestones, right? Where are we with the milestones?
View on StockTwits ↗$OPNT Still want to know why we sold so cheaply???
View on StockTwits ↗$OPNT STILL pissed off we sold so cheaply :( On Wednesday, the FDA announced that Emergent Biosciences will extend the shelf-life of Narcan 4 milligram (mg) naloxone hydrochloride nasal spray products from 3-years to 4-years. The extension request is the latest of multiple steps that the FDA has taken to reduce overdose-related deaths.
View on StockTwits ↗$OPNT $HRTX So Collard featured 3 times with the FDA last week.....at least he is a part of OPIANT's story
View on StockTwits ↗$OPNT still pissed this sold.so cheaply seems criminal:(
View on StockTwits ↗$OPNT Considering that officer and paramedic carry nalaxone there sure to carry out product too.
View on StockTwits ↗$OPNT 800k police officers and 170k paramedics at $75 we can generate $70m revenue in USA alone let alone Europe and the rest of the markets.
View on StockTwits ↗$OPNT too bad we cant buy or sell on this damn stock!! Shes a dead cat!
View on StockTwits ↗$OPNT https://www.fda.gov/news-events/press-announcements/fda-approves-prescription-nasal-spray-reverse-opioid-overdose
View on StockTwits ↗$OPNT is this stock dead? no movement all day! dont have a position in this one. waiting on PDUFA approval before jumping in supposed to be today. BPMC just got approved.
View on StockTwits ↗$OPNT this was to be our PDUFA date week. Well, perhaps we’ll get something from the CVrs.
View on StockTwits ↗@iamabearbull He does this on the regular according to Bio. Involved in multiple companies. Net worth on net says nearing $20 mil- betting a lot more on paper. Company he’s also involved with- Opiant Pharmaceuticals $OPNT traded for near $40 Jan 2022, dipped to $7’s late summer, sold in Nov 2022 for $20 a share- Longs seemed more than pissed. May be great news for those getting in now at these levels, but I believe dies not bode well for any longs here with double digit avg. Time will tell.. some here thing 12-24 months.
View on StockTwits ↗$OPNT have any of you OG’s moved your money over to $EBS yet? I’d love to get your thoughts.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.